Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
Go back to Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.98 | 52 Week High | $19.75 | |||
| Open | $14.98 | 52 Week Low | $4.26 | |||
| Day High | $14.98 | P/E | N/A | |||
| Day Low | $14.98 | EPS | $0.00 | |||
| Volume | 27,238 | |||||
